Thailand planning to extend compulsory licences for two HIV drugs
This article was originally published in Scrip
Thailand has proposed extending compulsory licences for two antiretroviral drugs for HIV/AIDS until the end of their local patent life.
You may also be interested in...
Product review report reveals multiple delays and missteps on route to market, holding valuable lessons for other gene therapy developers but also evidencing an ultimately welcoming environment.
Join us for a quick audio roundup of major developments in the international biopharma industry over the past week, as covered by Scrip's global team.
Positive clinical results pave path forward for Japanese firm’s potential istradefylline successor.